v3.25.2
Business Combinations - Summary of Preliminary Estimated Fair Values of Assets Acquired and Liabilities Assumed (Detail) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Dec. 19, 2024
Assets Acquired      
Goodwill $ 41,745 $ 40,330  
Sherlock Biosciences      
Assets Acquired      
Other current assets     $ 2,570
Property, plant, and equipment, net     9,244
Other noncurrent assets     462
Operating right-of-use assets     4,080
In-process research and development technology intangible asset     17,000
Goodwill     6,382
Total assets acquired     39,738
Liabilities Assumed      
Accounts payable     2,449
Current liabilities     3,621
Deferred revenue     1,641
Operating lease liability     4,080
Total liabilities assumed     11,791
Net Assets Acquired     27,947
Estimated fair value of contingent consideration     (22,910)
Net Cash Paid (net of cash acquired of $402)     5,037
Cash acquired in excess of payments to acquire business     $ 402